RNGTT
mRNA-capping enzyme
Also known as: hCAP, HCE, HCE1, MCE1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60942
- Gene
- RNGTT
- Ensembl
- ENSG00000111880
- Chromosome
- 6
- Canonical length
- 597 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables inorganic triphosphate phosphatase activity and mRNA guanylyltransferase activity. Involved in 7-methylguanosine mRNA capping. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
597 residues, UniProt reviewed canonical sequence.
>O60942|RNGTT
1 MAHNKIPPRW LNCPRRGQPV AGRFLPLKTM LGPRYDSQVA EENRFHPSML SNYLKSLKVK
61 MGLLVDLTNT SRFYDRNDIE KEGIKYIKLQ CKGHGECPTT ENTETFIRLC ERFNERNPPE
121 LIGVHCTHGF NRTGFLICAF LVEKMDWSIE AAVATFAQAR PPGIYKGDYL KELFRRYGDI
181 EEAPPPPLLP DWCFEDDEDE DEDEDGKKES EPGSSASFGK RRKERLKLGA IFLEGVTVKG
241 VTQVTTQPKL GEVQQKCHQF CGWEGSGFPG AQPVSMDKQN IKLLDLKPYK VSWKADGTRY
301 MMLIDGTNEV FMIDRDNSVF HVSNLEFPFR KDLRMHLSNT LLDGEMIIDR VNGQAVPRYL
361 IYDIIKFNSQ PVGDCDFNVR LQCIEREIIS PRHEKMKTGL IDKTQEPFSV RNKPFFDICT
421 SRKLLEGNFA KEVSHEMDGL IFQPTGKYKP GRCDDILKWK PPSLNSVDFR LKITRMGGEG
481 LLPQNVGLLY VGGYERPFAQ IKVTKELKQY DNKIIECKFE NNSWVFMRQR TDKSFPNAYN
541 TAMAVCNSIS NPVTKEMLFE FIDRCTAASQ GQKRKHHLDP DTELMPPPPP KRPRPLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNGTT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 16 nTPM
- lymph node: 16 nTPM
- thymus: 14 nTPM
- retina: 9.8 nTPM
- bone marrow: 9 nTPM
- testis: 8.7 nTPM
Single-cell type
- neutrophil progenitors: 425 nCPM
- ependymal cells: 337 nCPM
- monocyte progenitors: 258 nCPM
- rod photoreceptor cells: 222 nCPM
- b-cells: 219 nCPM
- pituicytes/fscs: 217 nCPM
Immune cell
- memory B-cell: 23 nTPM
- naive B-cell: 23 nTPM
- NK-cell: 11 nTPM
- naive CD8 T-cell: 10 nTPM
- memory CD8 T-cell: 9.7 nTPM
- naive CD4 T-cell: 9.7 nTPM
Brain region
- cerebellum: 21 nTPM
- hypothalamus: 16 nTPM
- cerebral cortex: 13 nTPM
- midbrain: 12 nTPM
- pons: 12 nTPM
- white matter: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.37
- gnomAD missense Z
- 3
- DepMap mean gene effect
- -1.86
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- GTP binding
- phosphoprotein phosphatase activity
- polynucleotide 5'-phosphatase activity
- inorganic triphosphate phosphatase activity
- mRNA 5'-triphosphate monophosphatase activity
- mRNA guanylyltransferase activity
- RNA guanylyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Nucleic acid-binding, OB-fold
- Protein-tyrosine phosphatase, active site
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Dual specificity phosphatase, catalytic domain
- mRNA capping enzyme, adenylation domain
- mRNA capping enzyme, C-terminal domain
- mRNA capping enzyme, bifunctional
- mRNA capping enzyme, catalytic domain
- mRNA capping enzyme, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNGTT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNGTT as an antibody target. Whether an autoantibody or antibody against RNGTT could matter depends on whether native RNGTT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNGTT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNGTT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...